Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.

OBJECTIVE: To assess whether monoclonal antibody to tumor necrosis factor alpha (TNF alpha) reduces endothelial activation in rheumatoid arthritis (RA). METHODS: Levels of serum E-selectin, intercellular adhesion molecule 1 (ICAM-1), and vascular cell adhesion molecule 1 (VCAM-1), and circulating le...

Full description

Bibliographic Details
Main Authors:	Paleolog, E, Hunt, M, Elliott, M, Feldmann, M, Maini, R, Woody, J
Format:	Journal article
Language:	English
Published:	1996

Similar Items

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1997)

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
by: Elliott, M, et al.
Published: (1994)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
by: Elliot, M, et al.
Published: (2008)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
by: Elliott, M, et al.
Published: (1993)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
by: Feldmann, M, et al.
Published: (1997)

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
by: Paleolog, E, et al.
Published: (1998)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
by: Maini, R, et al.
Published: (1995)

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
by: Maini, R, et al.
Published: (1998)

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1994)

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
by: Taylor, P, et al.
Published: (2000)

Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.
by: Maini, R, et al.
Published: (1995)

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.
by: Elliott, M, et al.
Published: (1994)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
by: Brennan, F, et al.
Published: (1995)

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
by: Davis, D, et al.
Published: (1997)

Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus.
by: Maini, R, et al.
Published: (1994)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
by: Feldmann, M
Published: (1996)

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
by: Maini, R, et al.
Published: (1999)

Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor alpha therapy in rheumatoid arthritis - Reply
by: Maini, R, et al.
Published: (1998)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
by: Maini, R, et al.
Published: (1994)

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.
by: Chu, C, et al.
Published: (1991)

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
by: Elliott, M, et al.
Published: (1995)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1995)

TNF alpha as a therapeutic target in rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1994)

Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis.
by: Tak, P, et al.
Published: (1996)

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
by: Charles, P, et al.
Published: (2000)

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha.
by: Haworth, C, et al.
Published: (1991)

TNF alpha--a pivotal role in rheumatoid arthritis?
by: Brennan, F, et al.
Published: (1992)

Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells.
by: Paleolog, E, et al.
Published: (1994)

Similar effects of pulse corticosteroid and tumor necrosis factor a blockade in rheumatoid arthritis: Reply
by: Taylor, P, et al.
Published: (2001)

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
by: Feldmann, M, et al.
Published: (1995)

Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.
by: Buchan, G, et al.
Published: (1988)

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
by: Williams, R, et al.
Published: (2000)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (2001)

Increased expression of HLA-DQ antigens by interstitial cells and endothelium in the synovial membrane of rheumatoid arthritis patients compared with reactive arthritis patients.
by: Barkley, D, et al.
Published: (1989)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
by: Feldmann, M, et al.
Published: (2001)

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha.
by: Deleuran, B, et al.
Published: (1992)

Contrasting effects of interferon gamma and interleukin 4 on responses of human vascular endothelial cells to tumour necrosis factor alpha.
by: Paleolog, E, et al.
Published: (1992)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
by: Maini, R, et al.
Published: (1993)

Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.
by: Ulfgren, A, et al.
Published: (2000)

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.
by: Maini, R, et al.
Published: (1999)